299 related articles for article (PubMed ID: 18796624)
1. Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis.
Lannutti BJ; Epp A; Roy J; Chen J; Josephson NC
Blood; 2009 Feb; 113(8):1778-85. PubMed ID: 18796624
[TBL] [Abstract][Full Text] [Related]
2. Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes.
Tiedt R; Coers J; Ziegler S; Wiestner A; Hao-Shen H; Bornmann C; Schenkel J; Karakhanova S; de Sauvage FJ; Jackson CW; Skoda RC
Blood; 2009 Feb; 113(8):1768-77. PubMed ID: 18845793
[TBL] [Abstract][Full Text] [Related]
3. Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation.
Ng AP; Kauppi M; Metcalf D; Hyland CD; Josefsson EC; Lebois M; Zhang JG; Baldwin TM; Di Rago L; Hilton DJ; Alexander WS
Proc Natl Acad Sci U S A; 2014 Apr; 111(16):5884-9. PubMed ID: 24711413
[TBL] [Abstract][Full Text] [Related]
4. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling.
Lebois M; Dowling MR; Gangatirkar P; Hodgkin PD; Kile BT; Alexander WS; Josefsson EC
J Thromb Haemost; 2016 Sep; 14(9):1882-7. PubMed ID: 27344013
[TBL] [Abstract][Full Text] [Related]
5. Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia.
Muraoka K; Ishii E; Tsuji K; Yamamoto S; Yamaguchi H; Hara T; Koga H; Nakahata T; Miyazaki S
Br J Haematol; 1997 Feb; 96(2):287-92. PubMed ID: 9029014
[TBL] [Abstract][Full Text] [Related]
6. Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.
Deutsch VR; Tomer A
Br J Haematol; 2013 Jun; 161(6):778-93. PubMed ID: 23594368
[TBL] [Abstract][Full Text] [Related]
7. Thrombopoietin from beginning to end.
Hitchcock IS; Kaushansky K
Br J Haematol; 2014 Apr; 165(2):259-68. PubMed ID: 24499199
[TBL] [Abstract][Full Text] [Related]
8. Developmental Stage-Specific Manifestations of Absent TPO/c-MPL Signalling in Newborn Mice.
Lorenz V; Ramsey H; Liu ZJ; Italiano J; Hoffmeister K; Bihorel S; Mager D; Hu Z; Slayton WB; Kile BT; Sola-Visner M; Ferrer-Marin F
Thromb Haemost; 2017 Dec; 117(12):2322-2333. PubMed ID: 29212120
[TBL] [Abstract][Full Text] [Related]
9. [Congenital amegakaryocytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl].
Germeshausen M; Schulze H; Gaudig A; Krukemeier S; Strauss G; Welte K; Ballmaier M
Klin Padiatr; 2001; 213(4):155-61. PubMed ID: 11528548
[TBL] [Abstract][Full Text] [Related]
10. Congenital amegakaryocytic thrombocytopenia iPS cells exhibit defective MPL-mediated signaling.
Hirata S; Takayama N; Jono-Ohnishi R; Endo H; Nakamura S; Dohda T; Nishi M; Hamazaki Y; Ishii E; Kaneko S; Otsu M; Nakauchi H; Kunishima S; Eto K
J Clin Invest; 2013 Sep; 123(9):3802-14. PubMed ID: 23908116
[TBL] [Abstract][Full Text] [Related]
11. Signals emanating from the membrane proximal region of the thrombopoietin receptor (mpl) support hematopoietic stem cell self-renewal.
Tong W; Ibarra YM; Lodish HF
Exp Hematol; 2007 Sep; 35(9):1447-55. PubMed ID: 17637498
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects on erythropoiesis, thrombopoiesis, and stem cell competitiveness in mice deficient in thrombopoietin and steel factor receptors.
Antonchuk J; Hyland CD; Hilton DJ; Alexander WS
Blood; 2004 Sep; 104(5):1306-13. PubMed ID: 15138166
[TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation.
Goncalves F; Lacout C; Villeval JL; Wendling F; Vainchenker W; Dumenil D
Blood; 1997 May; 89(10):3544-53. PubMed ID: 9160659
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopenia.
van den Oudenrijn S; Bruin M; Folman CC; Peters M; Faulkner LB; de Haas M; von dem Borne AE
Br J Haematol; 2000 Aug; 110(2):441-8. PubMed ID: 10971406
[TBL] [Abstract][Full Text] [Related]
15. An incomplete trafficking defect to the cell-surface leads to paradoxical thrombocytosis for human and murine MPL P106L.
Favale F; Messaoudi K; Varghese LN; Boukour S; Pecquet C; Gryshkova V; Defour JP; Albu RI; Bluteau O; Ballerini P; Leverger G; Plo I; Debili N; Raslova H; Favier R; Constantinescu SN; Vainchenker W
Blood; 2016 Dec; 128(26):3146-3158. PubMed ID: 28034873
[TBL] [Abstract][Full Text] [Related]
16. C-Cbl regulates c-MPL receptor trafficking and its internalization.
Märklin M; Tandler C; Kopp HG; Hoehn KL; Quintanilla-Martinez L; Borst O; Müller MR; Saur SJ
J Cell Mol Med; 2020 Nov; 24(21):12491-12503. PubMed ID: 32954656
[TBL] [Abstract][Full Text] [Related]
17. Role of promoter element in c-mpl gene expression induced by TPO.
Sunohara M; Morikawa S; Fuse A; Sato I
Okajimas Folia Anat Jpn; 2013; 89(4):131-5. PubMed ID: 23614986
[TBL] [Abstract][Full Text] [Related]
18. Regulation of hematopoietic stem cells by their mature progeny.
de Graaf CA; Kauppi M; Baldwin T; Hyland CD; Metcalf D; Willson TA; Carpinelli MR; Smyth GK; Alexander WS; Hilton DJ
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21689-94. PubMed ID: 21115812
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of c-Mpl ectodomain mutations that underlie congenital amegakaryocytic thrombocytopenia.
Varghese LN; Zhang JG; Young SN; Willson TA; Alexander WS; Nicola NA; Babon JJ; Murphy JM
Growth Factors; 2014 Feb; 32(1):18-26. PubMed ID: 24438083
[TBL] [Abstract][Full Text] [Related]
20. The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor.
Gainsford T; Nandurkar H; Metcalf D; Robb L; Begley CG; Alexander WS
Blood; 2000 Jan; 95(2):528-34. PubMed ID: 10627458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
